SENSORCAINE
- Product NDC
- 70518-2657
- 11-digit product format
- 705182657
- Labeler code
- 70518
- Product ID
- 70518-2657_cc71c354-0bd5-08bb-e053-2a95a90a7a2b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE
- Dosage form
- INJECTION, SOLUTION
- Route
- EPIDURAL; INTRACAUDAL; PERINEURAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA018304
- Marketing category
- NDA
- Marketing start
- 2020-03-25
- Marketing end
- 0000-00-00
- Substance
- BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
- Active strength
- 5 mg/mL; mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2657-0 | 70518265700 | 25 VIAL, SINGLE-DOSE in 1 TRAY (70518-2657-0) > 10 mL in 1 VIAL, SINGLE-DOSE (70518-2657-1) | 2020-03-25 | 0000-00-00 | No | No | Current |